Navigation Links
Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
Date:2/28/2008

Nordic Biotech II K/S and MPM BioVentures close on additional $6 million

investment on top of $75 million previous investment

AMSTERDAM, Netherlands and ALAMEDA, Calif., Feb. 28 /PRNewswire/ -- Arriva Pharmaceuticals, a biopharmaceutical company focused on developing anti- inflammatory therapies for treating respiratory diseases, completed a financing of 6 million USD led by new Investor Nordic Biotech II K/S and with participation by MPM BioVentures. Since its founding in 1997, Arriva has now raised a total of 81 million USD.

"Key financing from Nordic Biotech II KS and from our earlier lead investor, MPM Capital, allows us to continue the development of recombinant alpha-one antitrypsin for hereditary emphysema," said Sue Preston, CEO, Arriva Pharmaceuticals. "With a committed, experienced management team, we are now focused on the clinical development of our lead and pipeline products."

"We are investing in the clear value we see in Arriva's late-stage inhaled protein rAAT, a replacement product for the treatment of hereditary emphysema," said Florian Schonharting, partner of Nordic Biotech. "Our goal with Arriva is to provide financing and through board participation, help the company become a recognized, fully integrated biotech concern," added Christian Hansen, partner of Nordic Biotech.

"MPM has been a supporter of Arriva and the company's mission since 2002," said Ansbert Gadicke, General Partner, MPM Capital. "We continue to believe that there is significant potential in the company's respiratory product pipeline and are involved in this financing because we anticipate that Arriva will successfully capitalize on its IP and other assets."

About Arriva:

Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, chronic obstructive pulmonar
'/>"/>

SOURCE Arriva Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  Mallinckrodt plc (NYSE: MNK ) announced ... share repurchase program. The open-ended authorization permits the company ... ordinary shares. "Funding additional initiatives and ... we continue to pursue a range of focused growth ...
(Date:1/22/2015)... Jan. 22, 2015  BiOptix is pleased to announce the ... President of Chemistry and Biochemistry. Scott joins the company after ... and Amgen throughout the course of his nearly 20 ... "Scott is a nationally recognized thought leader in the ...
(Date:1/22/2015)...  Bio-Techne Corporation (NASDAQ: TECH ) announced today ... the new Simple Plex platform through its Proteins Platform ... re-branding of the previously acquired CyPlex instrument platform from ... transformative immunoassay technology which integrates an innovatively designed microfluidic ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3
... Diagnostics Incorporated (NYSE: DGX ), the world,s ... that for the third quarter ended September 30, 2010, ... $1.13 per diluted share, from $192 million, or $1.02 ... Third quarter 2010 results include a benefit of $0.08 ...
... Stryker Corporation (NYSE: SYK ) reported operating ... Third Quarter Highlights ... as reported) to $1,768 million Orthopaedic Implants sales increased ... MedSurg Equipment sales increased 16.3% on a constant currency ...
Cached Medicine Technology:Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 2Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 3Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 4Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 5Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 6Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 7Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 8Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 9Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 10Quest Diagnostics Reports Third Quarter 2010 Financial Results; Updates Guidance for 2010 11Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 2Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 3Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 4Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 5Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 6Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 7Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 8
(Date:1/22/2015)... 2015 Liberty University has received accreditation for ... from the Council for Accreditation of Counseling & Related ... Center for Counseling & Family Studies , is under ... university’s new School of Behavioral Sciences. Prior to the formation ...
(Date:1/22/2015)... January 22, 2015 Woodloch Pines, an ... been selected by TripAdvisor as the number one best large ... best in the world for their annual Travelers’ Choice Awards. ... community . The website is home to millions of unbiased ...
(Date:1/22/2015)... January 23, 2015 VogueQueen is a seasoned ... prices and many designers are thrilled to have it lead ... announces its new collection of prom dresses for the global ... drive the strategic vision and he focuses on continuing the ...
(Date:1/22/2015)... 22, 2015 Blue Cross and Blue Shield ... exemplify what it means to “Live Fearless.” , ... to share their stories about how they or someone they ... others by living in the moment. By telling these types ...
(Date:1/22/2015)... Orlando, Florida (PRWEB) January 22, 2015 ... up today at the 2015 PGA Merchandise Show to ... lady and incredible female amateur golfer, Arlene McKitrick. The ... career female amateur golf tournament win. She won her ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3
... WASHINGTON -- The U.S. Food and Drug Administration,s abilities ... outbreaks of foodborne illness are hampered by impediments to ... approach to gathering and using information on risks, says ... National Research Council. To more proactively tackle ...
... health care reform law provides health insurance coverage to ... as low as reasonably possible, according to a new ... that would have covered more Americans at a lower ... substantially higher penalties for those who don,t comply ...
... WASHINGTON The Health Impact Project, a collaboration of the ... announced more than $1 million in grants to six projects ... local levels. A health impact assessment (HIA) is ... proposed project or policy could affect the well-being of the ...
... , WEST LAFAYETTE, Ind. - Researchers at Purdue University ... testing food and water for contamination, and crime-scene forensics. ... electric fields to position droplets and tiny particles, such ... the drops. Other methods using either light or ...
... drinkers who order super-premium vodka in every martini or vodka-and-cranberry, ... snobs, who pay $60 for a bottle of a "tasteless" ... counterpart? Or is there really a scientific basis for the ... liquor? Scientists are reporting the first identification ...
... published in the American Journal of Public Health ... sub-Saharan Africa. The study analyzed data from 44 sub-Saharan African ... higher the country,s incidence of TB. The research concluded that ... cases annually may be attributable to mining. "We ...
Cached Medicine News:Health News:FDA should adopt risk-based approach to food safety 2Health News:FDA should adopt risk-based approach to food safety 3Health News:Few health reform options would have covered more people at lower cost than new law, study finds 2Health News:RWJF and Pew award 6 grants to examine the impact of policy on people's health 2Health News:RWJF and Pew award 6 grants to examine the impact of policy on people's health 3Health News:RWJF and Pew award 6 grants to examine the impact of policy on people's health 4Health News:RWJF and Pew award 6 grants to examine the impact of policy on people's health 5Health News:New method manipulates particles for sensors, crime scene testing 2Health News:New method manipulates particles for sensors, crime scene testing 3Health News:Brand preference may be in the drink, not in the head 2Health News:Study: Mining is a major driver of sub-Saharan Africa's TB epidemic 2
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use....
... newest addition to the Primus family of ... combination of speed and accuracy in a ... volume testing. Test results in 2 minutes ... the lab or clinic., ,The PDQ system ...
... Monoclonal antibody method for HbA1c provides ... shows 99% agreement with the HPLC method(1) ... a CV of 2.6%* means your ... Program (NGSP) certified method, as recommended by ...
... is a manual hemostasis analyzer that ... assays - PTs, aPTTs, thrombins, fibrinogens ... inexpensive, low-volume testing, this analyzer is ... features, offering time and labor saving ...
Medicine Products: